What Is Likely To Happen With The New Rise In Covid Cases
By Saksham Bhatia +2 more
Get more insightful and
helpful tips to
treat Diabetes for FREE
Download PharmEasy App
Register to Avail the Offer
Send OTPBy continuing, you agree with our Privacy Policy and Terms and Conditions
By Saksham Bhatia +2 more
After two years of grappling with Covid and its resultant crises (health and economy), 2022 has been a year without significant fatalities. People had returned to their pre-Covid lifestyles and breathed a sigh of relief.
However, the world has been alarmed by the news of a prospective new wave of Covid. Covid cases are rising in China. A new sub-variant of Omicron is the reason behind the new cases.
Table of Contents
Rising Covid cases in China have brought the international scanner on the new sub-lineage of Omicron, BF.7. The number of Covid cases in the US, South Korea and Brazil has also increased, as per reports. In most likelihood, it has appeared in many European countries as well.
A handful of cases have been found in India as well.
The Union Health Ministry has reassured the nation that there has not been an overall increase in caseload and the situation is being monitored. All states have been requested to continue genome sequencing to track the progress of this new sub-variant and understand it better.
What we know for certain is that Omicron BF.7 is much more transmissible than its precursors. It has an R-value of 10-18.6, meaning one infected person can spread it to between ten to eighteen people.
But is it more dangerous than the other variants? Most likely, it isn’t. However, as is the nature of all viruses, Covid variants are mutating and this is why Omicron BF.7 may be able to dodge immunity formed by vaccination or by prior exposure and become more transmissible.
It is too early to say what dimensions this new situation will take. The vaccination response in India has been a rousing success and most of the population has been vaccinated.
In this context, doctors are recommending the booster dose to people. We also have a new intranasal vaccine now available on Co-Win App for precautionary doses.
According to many reports, only about 4% of the population chose to get the booster shot. Now would be a good time to get the booster jab. It will shore up immunity to ready us for a possible new outbreak.
The good news is some experts are stating that the infections may not be anywhere close to as severe as those caused by the Delta variant. There will likely not be a drop in oxygen saturation level or breathing issues. But given the number of deaths reported in China, we must be careful and exercise all precautions.
But the volume of cases, owing to how contagious the variant is, is a little worrying.
BF.7, being a sublineage of Omicron, will likely present Omicron-like symptoms. As we have seen in previous waves- this variant can cause a full spectrum of diseases ranging from asymptomatic to severe illness.
Let’s not panic but follow Covid appropriate behaviour sincerely. Here are some tips-
Covid was never gone. Like influenza, it may always stay with us. But through immunisation (by both infection and vaccination) and the passage of time, the population becomes better equipped to deal with a virus. However, that does not mean we can reject caution. As and when the government suggests, we should follow Covid mandates so that we can quickly return to our normal lives.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
Comments